Download presentation
Presentation is loading. Please wait.
Published byBlanche Cummings Modified over 6 years ago
1
Chaper 13 Respiratory failure Zhao Mingyao BMC.ZZU
2
Respiration = ventilation + gas exchange
Ventilation: alveoli enlarging to set up P gradient airway fluency to let gas flow gas exchange: area distance efficiency (V/Q) physiology view
4
1.Concept of Repiratory Failure
Respiratory system fails to adequately oxygenate the blood with/without retention of CO2, it is generally defined as a PaO2 < 60mmHg, with /without PaCO2 >50mmHg
5
2.Classification of ~ (1)duration (2)primary site
According to (1)duration Acute : minutes to days Chronic: over months to years (2)primary site Central : head injury, encephalitis Peripheral: asthma, pneumonia, emphysema
6
(3)blood-gas Type I : PaO2 Type II: PaO2 + PaCO2 (4)pathogenesis
ventilation blood gas exchange: diffusion V/Q anatomy shunt ----O2 exchange ----alveolar hypoventilation
7
Section 1 Etiology and pathogenesis
Respiration = ventilation + gas exchange
8
Mechanism of RF 1. Hypoventilation (1)restrictive ~ (2)obstructive ~
Extralung intralung (1)restrictive ~ (2)obstructive ~ Ventilatory disorders () Central airway ~ Peripheral airway ~
9
Ventilation (does work)
= dynamic force overcomes resistant force (elastic ~ + nonelastic ~) ----physics view
10
(1) Restrictive ~ Major Causes: CNS and nerves
Respiratory muscles, chest wall and pleura Lung( Alveoli) distension distensibility Alveoli distensibility
11
1)Extrapulmonary disease
①CNS: ②Respiratory muscles: ③Chest wall and pleura: Lung distension drugs, infections, Cerebrovascular accident fatigue, atrophy, hypokalemia Fracture of ribs, pleura fibrosis Acute organophosphorus poisoning 抑制 acetylcholinesterase,AChE causes
12
Lung distension Pneumonia, fibrosis ,congestion Pulmonary edema &
2)Intrinsic disease ①Pulmonary elastic structure Lung distension Pneumonia, fibrosis ,congestion Pulmonary edema & ②Alveolar surfactant substance
13
Function of surfactant substances
1. Reduces surface tension 2. Increases compliance, stabilize alveoli Keep alveoli dry; Prevent pulmonary edema
14
3)Blood gas change PACO2 PAO2=PiO2 ———— R PAO2 P O2 in alveoli
Alveolar;arterial PAO P O2 in alveoli PiO2 : PO2 in inhaling air PACO2 :PCO2 in alveoli R:respiratory quotient
15
PCO2 in alveoli 0.863Vco2 PaCO2= PACO2 = —————— VA
PACO2 : PCO2 in alveoli Vco2:CO2 production/min VA :alveolar ventilation volume
16
Blood gas change PACO2 R 0.863Vco2 PaCO2= PACO2 = —————— VA
PAO2= PiO2 —————— R Alveolar;arterial PACO2 : PCO2 in alveoli Vco2:CO2 production/min VA :alveolar ventilation volume 0.863Vco2 PaCO2= PACO2 = —————— VA 16
17
Blood-Gas changes Ventilatory disorder Restrictive obstructive
Alveolar ventilatory volume PaO2 and PaCO2 proportionately PaO2 + PaCO2
18
(2) Obstructive ventilatory disorders
Tracheobronchial tree narrowing
19
Airway narrowing 1)Central airway obstruction
Airway above or below carina Airway narrowing Variable narrowing Fixed narrowing
20
outside thorax---inspiratory dyspnea
Variable expiration inspiration outside thorax---inspiratory dyspnea
21
Retractions ( supraclavicular, intercostal and subcostal areas)
retraction of soft tissue on inspiration concave a depression indentation hollow Retractions ( supraclavicular, intercostal and subcostal areas) on inspiration
22
Variable inspiration expiration inside thorax---expiratory dyspnea
23
2)Peripheral airway obstruction
24
Peripheral airway (Φ <2mm )
1. thinner wall, without cartilage support 2. caliber changes with respiration 3. close junction with adjacent tissues diameter Characteristics
25
Peripheral airway obstruction
1.mucosa edema 2.fibrosis 3.inflammatory infiltration 4.secretions in lumen thickness Bronchial asthma Chronic obstructive emphysema Chronic bronchitis diameter
26
Isobaric point upshift in Emphysema
Isobaric point 10 20 25 10 15 20 20 20 20 20 30 20 +35 35 20 20 25 +35 20 Normal expire Emphysema expire Isobaric point upshift in Emphysema
27
Mechanism of RF due to COPD
? a correlation between the increase in inflammation in the lungs and a loss of activity in an enzyme responsible for switching off inflammatory genes and cells, called histone deacetylase (HDAC).
28
Ventilation disorders Restrictive
CNS, NS Ventilation disorders Respiratory muscle Extrapulmonary Chest wall, pleura Restrictive Elastic structure intrapulmonary Surfactant substances outside inspiratory variable Central inside expiratory Obstructive resistance force fixed both Peripheral isobaric point upshift caliber decrease expiratory
29
3)Blood gas change PO2 ? PCO2 ?
30
2. Diffusion disorder a disruption in the exchange of O2 or CO2 or both across the alveolar-capillary membrane
31
Total diffusion AREA is large
50~100 m2 Diffusion PATH is very small, <1 µm
32
1) Diffusion area Alveolar area : 80m2 at rest: 40 m2
Causes of decreased area: Emphysema for an average size adult Ventilation area Pulmonary tumor Pulmonary lobectomy
33
2) Diffusion distance Pulmonary edema, congestion Pulmonary fibrosis
Alveolar epithelium hyperplasia Hyaline membrane Alveolar-capillary membrane thickness
34
3) Diffusion time ↑ alveolar normal Thick alveolar membrane Pul vein
Pul Artery
35
3) Blood gas change distance PaO2 area solubility
Blood stream time solubility PaCO2 Normal or or diffusion ability Diffusion disorder
36
3. Mismatching Ventilation/perfusion
37
1)V/Q Causes: Mechanism:
Bronchial asthma, chronic bronchitis, obstructive pulmonary emphysema, pulmonary fibrosis Mechanism: venous admixture alveolar ventilation V/Q<0.8 Perfusion normal (functional shunt)
38
2)V/Q Causes: Mechanism:
Pulmonary arteriosclerosis, pulmonary thrombosis bronchiectasis, pulmonary tuberculosis Mechanism: alveolar ventilation normal deadspace-like ventilation V/Q>0.8 perfusion
39
Gas exchange disorder diffusion area ↓ diffusion distant ↑
efficiency (V/Q) V/Q ↓ -functional shunt V/Q ↑ -dead space-like ventilation anatomy shunt ↑ Bronchial vein dilating Arterial-venous short-way
40
3)Blood gas change V/Q: ventilation V/Q: perfusion PaO2 ,
PaCO2 N or or
41
4.Anatomic shunt (Right-to-left shunt)
Causes: atelectasis, pulmonary consolidation, bronchiectasis, A-V shunt open Mechanism: Admixture with unoxygenated blood
42
3)Blood gas change PO2 ? PCO2 ?
43
Respiratory failure restrictive inadequate alveolar ventilation
summary restrictive inadequate alveolar ventilation ventilatory (PaO2↓ PaCO2↑) obstructive Respiratory failure diffusion disorder Gas exchange (PaO2↓ PaCO2↑↓N) Ventilation-perfusion dismatching Anatomic shunt(V/Q=0)
44
Mechanism of ARDS ? ?
45
Mechanism of ARDS Pathogenic factors
Inflammatory cells and platelet activated Release proteinase, inflammatory mediators Microthrombosis Alveolar-capillary membrane damaged Permeability (continue)
46
hypoxemia pulmonary edema diffusion disorder atelectasis
functional shunt bronchus spasm dead space-like ventilation vascular constriction microthrombosis
47
Section 2 Alterations of function and metabolism in ~
48
Acid-base, electrolytes
Respiratory failure Acid-base, electrolytes disorder abnormal blood-gas reaction of systems compensation decompensation
49
1. Acid-base and electrolytes disturbance
Respiratory acidosis type II ~ retention of CO2 K+ Metabolic acidosis---hypoxia zymolysis anaerobic glycolysis lactic acid K+
50
Respiratory alkalosis
type I RF with hyperventilation K+ Mixed acidosis Res acidosis & met acidosis type II RF---hypoxia and hypercapnia K+ Res acidosis & met alkalosis Remove CO2 too fast hypokalemia
51
2.Alternation of respiratory system
Respiratory frequency Respiratory rhythm Causes: Primary diseases PaO2 , PaCO2
52
the shallow and rapid RR does not increase O2 supply
Effective alveolar ventilation = (tidal volume – dead space)×RR (500 – 150) × 12 = 4.2 L normal (250 – 150) × 24 = 2.4 L shallow & rapid (250 – 150) × 6 = 0.6 L shallow & slow (1000 – 150) ×24= 20.4 L deep & rapid
53
Respiratory center + + - - PaO2 (30 ~ 60mmHg) PaCO2(<70mmHg)
peripheral chemoreceptor central chemoreceptor + + Respiratory center - - PaO2 PaCO2 <30mmHg >70mmHg
54
3. Alternation of circulatory system
Mild and medium PaO2 Circulatory center PaCO2 Severe
55
Pulmonary heart disease (cor pulmonale )
~ caused by pulmonary disease with the characteristics of pulmonary hypertension Mechanism: (1)Pulmonary hypertension---arteriolar constriction (2)Pulmonary blood flow resistance---RBC (3)Myocardial function---hypoxia, acidosis (4)forced expiration and inspiration cor pulmonale
56
4. Alternation of CNS Pulmonary encephalopathy: Cerebral dysfunction caused by severe respiratory failure Manifestation Excitation, headache, dysphoria Confusion, drowsiness, coma Death
57
Mechanism of Pulmonary encephalopathy
Membrane potential Hypoxemia---ATP Na+ pump brain edema Cerebral vessels dilation Hypercapnia--- Cell acidosis PaCO2>80mmHg CO2 narcosis
58
PaO2、 PaCO2 changes and CNS changes
PaO2 60 : intelligence,eyesight decrease mildly 40-50: mental manifestation 20 : irreversible damage of neural cells PaCO2 >80, CO2 narcosis, CNS symptoms mmHg mmHg mmHg millimetre(s) of mercury 毫米汞柱(液压单位) mmHg
59
Section 3 principles of prevention and treatment
I. Treat primary causes II. Relieve hypoxia and hypercapnia III. Treat other complications control infection
60
Oxygen administration
1. Type I : <50% O2 2. Type II : continuously Low concentration: <30% O2 Low current amount: L/min PaO2 = 60mmHg
61
Decreasing PaCO2 Relieve obstruction Increase drive of respiration
for type II RF, CO2 can’t be reduced too fast Increase drive of respiration Mechanical ventilator Nutrition supply
62
Airway Foreign Bodies Heimlich method
儿童在进食、玩耍瓜子、豆类、花生、扣子等物时,常因突然惊吓、跌倒、哭笑等将异物吸入气管。成人多因口中含物,如铁钉等不慎吸入,或因昏迷时将呕吐物、假牙吸入气管。气管受到异物刺激,突然出现剧烈咳嗽、喘鸣、呼吸和吞咽困难、声音嘶哑、面色苍白,继之变为青紫,甚而失去知觉,昏倒在地。若不及时抢救,异物完全堵塞气管,超过4分钟就会危及生命,即使抢救成功,也会留下瘫痪、失语等严重后遗症。如果仅堵塞部分气管,但又咯不出来,就可能发生肺炎、肺不张。因此,最关键的措施是在现场即刻将异物排出。 急救方法 现场急救最为理想的办法是美国医学会推荐的海利希手法。海利希手法适用于自救,也可用于互救。 1、站位急救法:救护者站在患者身后,用双臂围绕患者腰部,一手握拳,拳头的拇指侧顶在患者的上腹部(脐稍上方);另一手握住握拳的手,向上、向后猛烈挤压患者的上腹部。挤压动作要快速,压后随即放松。 2、卧位急救法:患者仰卧,救护者两腿分开跪在患者大腿外侧的地面上,双手掌叠放在患者脐稍上方,向下、向前快速挤压,压后随即放松。 3、儿童急救法:让患儿俯卧在两腿间,头低脚高,然后用手掌适当用力在患儿的两肩胛骨间拍击4次。拍背不见效,可让患儿背贴于救护者的腿上,然后,救护者用两手食指和中指用力向后、向上挤压患儿中上腹部,压后即放松,可重复几次,必要时急送医院。 Heimlich method
64
Thank you!
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.